SynopsisRevcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The global Elapegademase-lvlr Drugs market size is expected .....
SynopsisPanhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood. The global Panhematin Drugs market size is expected to reach US$ 56 million by 2029, growing at a CAGR .....
SynopsisVaccine for Akabane disease The global Akabane Vaccines market size is expected to reach US$ 91 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Akabane Vaccines in various end u.....
SynopsisFlexible Endoscope used in ENT The global ENT Flexible Endoscopes market size is expected to reach US$ 678.4 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of ENT Flexible Endosco.....
SynopsisHemostasis or haemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. The global Hemostasis Products market size is e.....
SynopsisDehydration, in general, is a body condition where there is deficit of water in the human body that is accompanied with disruption of metabolic processes taking place inside the body. The global Dehydration Monitoring Systems market size is expected to .....
SynopsisRecombinant antihemophilic factor works by temporarily raising levels of factor VIII in the blood to aid in clotting. The global Recombinant Antihemophilic Factor market size is expected to reach US$ 2994.2 million by 2029, growing at a CAGR of 4.8% from.....
Synopsis Clear aligners are orthodontic devices that are a transparent, plastic form of dental braces used to adjust teeth. Clear-aligner treatment involves an orthodontist or dentist, or with home-based systems, the person themselves, taking a mold of.....
SynopsisDiabetes mellitus is the main disease of Glycogen Metabolism Disease. The global Glycogen Metabolism Disease Drug market size is expected to reach US$ 112580 million by 2029, growing at a CAGR of 11.0% from 2023 to 2029. The market is mainly driven by th.....
SynopsisTysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried .....
